2-Methylimidazole D3


Product Details

CAT No.# CS-T-82505
Category Stable Isotopes
CAS 83413-07-4
Molecular Weight 85.12
Molecular Formula C₄H₃D₃N₂
Melting Point: 129-137°C (dec.)
Solubility: Chloroform (Slightly), Methanol (Slightly)
Appearance: White to Off-White Solid
Synonyms: 2-(Methyl-d3)-1H-imidazole; 1H-2-Methylimidazole-d3; 2-Methyl-1H-imidazole-d3; 2MZ-d3; 2MZ-H-d3; 2MZ-PW-d3; Actiron 2MI-d3; Curezol 2MZ-d3; Curezol 2MZ-P-d3; Denka CN 25-d3; Epicure MI 2-d3; Epikure MI 2-d3; Imicure AMI 2-d3; NSC 21394-d3
Application Notes: 2-Methylimidazole-d3 is the isotope labelled analog of 2-Methylimidazole; a monomethylated imidazole that can be used as a building block in the preparation of a wide range of biologically active compounds. 2-Methylimidazole as well as other imidazoles can be use as catalyst for refolding of enhanced coloured fluorescent protein. 2-Methylimidazole has been identified as a byproduct of fermentation and is detected in foods and mainstream and side-stream tobacco smoke.
Storage: For long term store at -20°C
Shipping: Free Shipping for worldwide on order above 2000 USD , Extra charges for Dry ice shipment 80$*
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Benidipine D7
4. Lauroside D
5. Triazolam 13C D3
6. Icatibant impurity 1
8. 0.1% TFA in Water ULC-MS
9. Metamizole EP Impurity C HCl
10. Silodosin Metabolite D4
11. Brivaracetam Carboxylic acid metabolite [UCB 42145]
12. Terbuthylazine D5
13. tibolone (848)
14. (Z)-Dimethylvinphos
15. Silodosin Metabolite
16. 2-Phenoxymethanesulfonanilide
17. Nimesulide EP Impurity A
18. Acetone HPLC
19. Nandrolone Decanoate EP impurity F
20. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline

This page contains information about 2-Methylimidazole D3 Cas 83413-07-4 and its Stable Isotopes.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."